Michael Zinda, EVP, Chief Science Officer at Repare Therapeutics Inc. (RPTX), sold 40,000 shares at $33.08 ($1.3M) on 2020-12-21, disclosed to the SEC on 2020-12-22.
Open-market sale of $1.3M RPTX by EVP, Chief Science Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| RPTX | SELL | 2024-03-27 | $6K | — | Filing → |
| RPTX | SELL | 2023-06-09 | $189K | — | Filing → |
| RPTX | SELL | 2023-06-07 | $14K | — | Filing → |